Treatment of human OSA cells with chemotherapeutics doxorubicin and methotrexate was shown to cause degradation of MST1/2 and decreases in LATS1/2 protein levels, the upstream regulators of TAZ/YAP. The gene discussed is YAP1; the disease is obstructive sleep apnea syndrome.